Scynexis Competitors and Similar CompaniesClear all
Scynexis's competitors and similar companies include Petra Pharma, Lixte Biotechnology and NGM Biopharmaceuticals.
 Scynexis Scynexis is engaged in drug discovery, development and manufacturing projects in various areas. |  Petra Pharma Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases. |  Lixte Biotechnology Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. |  NGM Biopharmaceuticals NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. | |
Founding Date | Founding Date 2000 | Founding Date 2016 | Founding Date 2006 | Founding Date 2007 |
Type | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Jersey City, US HQ | Locations New York, US HQ | Locations East Setauket, US HQ Pasadena, US | Locations South San Francisco, US HQ |
Employees | Employees 3636% decrease | Employees 20 | Employees 3 | Employees 18622% increase |
Valuation ($) | Valuation ($) 53 m | Valuation ($) N/A | Valuation ($) 2.9 m | Valuation ($) 128.5 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $20.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $4.4m (FY, 2023) |
Net income | Net income ($8.6m) (FY, 2025) | Net income N/A | Net income ($6m) (FY, 2025) | Net income ($142.4m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 48m | Total funding raised $ 1.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Petra Pharma
HQ
New York, US
Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.
View companyLixte Biotechnology
HQ
East Setauket, US
Employees
3
Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets.
View companyNGM Biopharmaceuticals
HQ
South San Francisco, US
Employees
186↑ 22% increase
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
View company